Phi Therapeutics, Inc.
Live biotherapeutic topical treatment using probiotic bacteria to replace pathogenic P. acnes and restore skin microbiome balance
- Sector
- Biotech
- Headquarters
- PETALUMA, CA
- Latest Form D
- $4.2M, Apr 2023
- Total capital
- $5.6M
- Federal grants
- $165K
- 1 award · 2015
- Rank in peer group#380 of 392
- Private capital raised
- $5.4M
- 3 Form D · last Apr 2023
- 43 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 4 pending · first 2024
- Rank in peer group#40 of 392
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$4.2M
- Private capital raisedForm D · SEC · 2nd filing$660K
- Private capital raisedForm D · SEC · 1st filing$575K
- Federal grantHealth and Human S · Phase I · Precise Microbiome Editing for the Treatment of Acne$165K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
45months
from Phi Therapeutics, Inc.’s first federal award to its first private round.
- First federal award · Sep 2015
- Health and Human S · $165K
- First Form D · Jun 2019
- $575K · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#40 · top 10%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- YUG VARMAResearcherExecutive Officer, DirectorLinked by 3 patents · $165K in grants as PI
- JUN LIDirectorNamed in SEC Form D filings
- KEVIN LAWDirectorNamed in SEC Form D filings
- Maria ChoDirector, PromoterNamed in SEC Form D filings
- NEIL GIUGNOExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 7- GrantedCompositions And Methods For The Treatment Of Skin Diseases And Conditions Including EczemaUSPTOUS 12,605,416
- GrantedCompositions Comprising Propionibacterium Acnes Bacteriophages For Treating AcneUSPTOUS 12,576,024
- GrantedCompositions Comprising Propionibacterium Acnes Bacteriophages For Treating AcneUSPTOUS 11,903,984
Show all 7 patent records
- Compositions And Methods For The Treatment Of Skin Diseases And Conditions Including EczemaApr 21, 2026 · US 12,605,416Granted
- Compositions Comprising Propionibacterium Acnes Bacteriophages For Treating AcneMar 17, 2026 · US 12,576,024Granted
- Compositions Comprising Propionibacterium Acnes Bacteriophages For Treating AcneFeb 20, 2024 · US 11,903,984Granted
- Compositions Comprising Propionibacterium Acnes Bacteriophages For Treating AcneNov 4, 2021 · Application 16606158Pending
- Compositions And Methods For The Treatment Of Skin Diseases And Conditions Including EczemaApplication 63493834Pending
- Compositions And Methods For The Treatment Of Skin Diseases And Conditions Including EczemaApplication PCTUS2024022657Pending
- Compositions Comprising Propionibacterium Acnes Bacteriophages For Treating AcneApplication PCTUS2018028556Pending
Related companies, and why
- Pretzel TherapeuticsSimilar federal contract value in Biotech · null in contracts
- COMPANION SCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- TAXIS PHARMACEUTICALS, INC.Similar federal contract value in Biotech · null in contracts
- GENERAL BIOPHYSICS, LLCSimilar federal contract value in Biotech · null in contracts
- DiaMedica Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- DURAVAX INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .